Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Granulation SOP Template: Critical Steps and Documentation Points

Posted on November 25, 2025November 25, 2025 By digi


Granulation SOP Template: Critical Steps and Documentation Points

Comprehensive Guide to Granulation Process Controls in Tablet Manufacturing

Granulation is a pivotal stage in tablet manufacturing, influencing critical quality attributes such as content uniformity, dissolution, and compressibility. Implementing precise granulation process controls in tablet manufacturing is essential for compliance with pharmaceutical Good Manufacturing Practice (GMP) requirements and to ensure batch-to-batch consistency. This detailed step-by-step tutorial provides a thorough SOP template illustrating essential granulation stages, associated documentation points, and regulatory considerations suited for manufacturers operating under the FDA, EMA, MHRA, PIC/S, and WHO GMP frameworks.

Step 1: Preparation and Pre-Granulation Checks

The initial phase in the granulation SOP involves meticulous preparation to guarantee that all materials, equipment, and personnel are ready prior to production. This foundational step mitigates risks of contamination, deviation, and batch failures.

Key Activities

  • Raw material verification: Confirm identity, quality, and expiry of active pharmaceutical ingredients (API), excipients, and granulating agents via Certificates of Analysis (CoA) and in-house testing.
  • Equipment preparation: Perform thorough cleaning according to validated cleaning procedures. Conduct visual inspections to ensure equipment integrity and cleanliness per FDA guidelines on cleaning and sanitation.
  • Environmental conditions: Verify that the granulation area meets environmental controls (e.g., temperature, humidity, and particulate levels) as defined in the manufacturing site’s validated parameters.
  • Personnel readiness: Ensure operators are trained, wearing appropriate PPE, and aware of the SOP requirements to reduce cross-contamination risks.
  • Batch documentation review: Retrieve and review the batch manufacturing record (BMR) including prior step outcomes to confirm readiness.

Documentation and Checks

Pre-production checks must be formally documented in the batch documentation, including:

  • Raw material receipt and inspection records
  • Equipment cleaning logs and maintenance records
  • Environmental monitoring data
  • Operator training and health status confirmations
  • Checklist completion confirming all prerequisites are met before granulation begins
Also Read:  SOP for Preparation and Approval of Batch Manufacturing Records

Ensuring full compliance with SOP requirements at this stage reduces deviations and supports overall product quality assurance.

Step 2: Mixing and Wet Granulation Process Controls

The granulation itself is a critical operation requiring strict process control to produce granules with consistent size distribution, moisture content, and flow properties. The SOP template must clearly define controlled parameters, acceptance criteria, and in-process checks for the mixing and wet granulation steps.

Mixing

Uniform mixing of dry powders is vital before granulation liquid addition. The following controls should be included:

  • Predefined mixing time and speed settings validated to achieve homogeneity
  • Visual and/or sample testing to confirm uniform blend
  • Monitoring of batch weight vs. target weight with documented tolerances

Wet Granulation

During wet granulation, the binder solution is added to the powder blend under controlled conditions:

  • Binder volume and composition: Use validated solutions with evidence of stability and lot control
  • Addition rate and shear: Monitor and control the rate of liquid addition to prevent overwetting or underwetting
  • Granulator speed and time: Set and verify impeller and chopper speeds, ensuring consistency with validated parameters
  • Real-time monitoring: Employ in-process controls such as torque measurement or power consumption to track granulation end-point

In-Process Checks and Acceptance Criteria

  • Granule moisture content testing using validated methods (e.g., loss on drying) at defined intervals
  • Granule size distribution sampling analyzed by sieve analysis or laser diffraction
  • Visual inspection for agglomerate formation or granule texture anomalies
  • Batch weight confirmation post-granulation

All measurements, deviations, and equipment parameters must be documented contemporaneously in the batch manufacturing record to comply with GMP traceability standards.

Step 3: Drying, Milling, and Post-Granulation Controls

After wet granulation, the drying process and subsequent milling require rigorous control to yield granules meeting the desired quality attributes.

Drying Process Controls

  • Drying equipment qualification: Confirm operation qualification (OQ) and preventive maintenance records comply with the current SOP.
  • Drying parameters: Preset temperature, airflow, and drying time guided by previous validation studies and in-process moisture measurements.
  • Moisture content testing: Use rapid and validated analytical techniques to determine end-point; document results against acceptance criteria to prevent degradation or insufficient drying.
  • Batch segregation: Ensure drying batches are clearly identified and segregated to avoid mixing or cross contamination.
Also Read:  How to Train Operators for Effective Visual Defect Detection

Milling Controls

  • Pre-milling equipment inspection and cleaning verification
  • Defined milling parameters including speed and screen size tailored to achieve target granule size without generating excess fines
  • Sampling plan for size distribution and fines content analysis
  • Equipment monitoring for abnormal vibrations or noises that may indicate mechanical issues

Post-Granulation Batch Documentation

Documentation must include:

  • Equipment settings and deviations recorded with timestamped operator signatures
  • All analytical results for moisture and granule size with reference to SOP methods
  • Any corrective actions taken during drying or milling phases, fully justified and approved
  • Updated process flow and component weights for granules prepared, enabling subsequent compression stage calculations

Maintaining this thorough documentation ensures that all personnel and inspectors can audit the process comprehensively, supporting regulatory compliance and continuous process improvement.

Step 4: Quality Assurance and Batch Release Considerations

Final granulation SOPs must integrate quality assurance (QA) checkpoints that validate process adequacy before granting batch release. These include:

In-Process Quality Control Sampling

  • Regular sampling of granules during manufacture for physical and chemical testing
  • Consistency checks against predefined specification limits for attributes such as particle size, moisture content, and flowability
  • Review of instrument calibration and analyst training records involved in QC testing

Batch Documentation Review and Approval

  • Complete review of the Batch Manufacturing Record by QA personnel for completeness and conformity with the SOP template
  • Verification that all deviations are documented and CAPA implemented effectively
  • Cross-verification of raw material lot numbers, quantity reconciliations, and in-process checks
  • Final batch release authorization following satisfactory compliance with regulatory and internal manufacturing standards

Compliance with overarching regulatory frameworks such as those outlined in EU GMP Volume 4 and the PIC/S GMP Guide are pivotal considerations at this stage. These standards emphasize traceability, risk management, and proper documentation reflecting all granulation process controls.

Also Read:  How to Train Operators for Effective Visual Defect Detection

Step 5: Common Challenges, Troubleshooting, and Continuous Improvement

The granulation process is subject to several common challenges including variability in raw material characteristics, equipment fluctuations, and environmental influences. An effective SOP template incorporates troubleshooting guidance and encourages continuous improvement.

Common Issues and Root Cause Analysis

  • Overwet or underwater granulation: Causes include incorrect binder addition rates or impaired equipment performance. Remedies must be clearly outlined in the SOP with adjustment procedures.
  • Inconsistent granule size distribution: Often due to improper mixing or milling parameters; sieve analysis data should trigger review and corrective actions.
  • Moisture content deviations: Can affect tablet compressibility and stability; environmental controls and drying process controls play a key role.

Incorporating Continuous Improvement

  • Regular analysis of batch data trends and deviations with quality teams
  • Updating SOPs and batch documentation templates to incorporate findings from investigations and audits
  • Investing in training and cross-functional reviews to improve operator adherence to checks and process understanding

Embedding risk-based quality management principles as promoted by ICH Q9 Quality Risk Management ensures that granulation process controls remain robust and responsive to operational variations.

Conclusion: Key Takeaways for Granulation SOP Template Implementation

Accurate and comprehensive control of the granulation process is a cornerstone of successful tablet manufacturing. A well-structured SOP template must incorporate detailed steps for preparation, mixing, granulation, drying, and milling, with embedded critical checks and rigorous documentation. Regulatory compliance is ensured by aligning process controls with FDA, EMA, MHRA, PIC/S, and WHO GMP expectations, emphasizing traceability, real-time monitoring, and quality review.

Companies should continuously evaluate and refine granulation practices based on manufacturing data and regulatory updates to maintain product quality and safeguard patient safety. By following this step-by-step guide, pharma manufacturing professionals in QA, QC, validation, and regulatory affairs can develop and maintain robust granulation SOPs that meet industry-leading standards and inspection readiness.

Granulation Controls Tags:critical steps, granulation, pharmagmp, sop, template

Post navigation

Previous Post: Trend Analysis of In-Process Data for Early Signal Detection
Next Post: Granulation Deviations: Lumps, Over-Wet Mass and Poor Flow

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme